Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Explainable AI boosts breast cancer detection on MRI
Experts involved in the model's development are hopeful their take on explainable AI can reduce problematic false positive rates common in breast MRI.
Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging
LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s.
Doppler ultrasound offers accurate, accessible alternative for diagnosing peripheral artery disease
Experts believe the method could be easily integrated into clinical settings and improve screening for PAD.
AI ups detection of small prostate lesions by nearly 20%
Many experts believe that artifcial intelligence could help address issues with reader variability on prostate MRIs.
AI-enhanced echocardiography improves early detection of cardiac amyloidosis
The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

Explainable AI spots more cancer on breast MRI

Explainable AI boosts breast cancer detection on MRI

Experts involved in the model's development are hopeful their take on explainable AI can reduce problematic false positive rates common in breast MRI.

Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging

LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s.

Doppler ultrasound offers accurate, accessible alternative for diagnosing peripheral artery disease

Experts believe the method could be easily integrated into clinical settings and improve screening for PAD.

AI ups detection of small prostate lesions by nearly 20%

Many experts believe that artifcial intelligence could help address issues with reader variability on prostate MRIs.

Ultromics EchoGo Amyloidosis artificial intelligence

AI-enhanced echocardiography improves early detection of cardiac amyloidosis

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

AI algorithm that diagnoses depression from MRI scans gains key regulatory approval

Experts are hopeful the software can bring more objectivity to the diagnostic process by giving providers visual evidence of alterations in brain activity.

Software glitch triggers FDA recall of nearly 2,000 GE SPECT and CT systems

According to the notification, the issue can cause the scanners to inadvertently move during imaging.

ASE shares new recommendations for evaluating LV diastolic function, HFpEF

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.